サマリー

医療用外骨格の世界市場規模は、2021年の2億米ドルから、2026年には10億米ドルになると予測され、年平均成長率は45.0%となっています。この市場の成長は主に、身体障害者の増加とそれに伴う効果的なリハビリアプローチへの需要の高まり、外骨格技術の開発のための企業や研究機関の合意や協力、いくつかの国での医療用外骨格への保険適用の増加などの要因が医療用外骨格市場の成長を牽引しています。ただし、医療用外骨格のコストが高いことが、市場の成長を一定程度制限する可能性があります。
"2020年の医療用外骨格市場では、ハードウェアセグメントが最大のシェア78.57%を占めると予想されています。"
2020年の医療用外骨格市場では、デバイスセグメントが最大のシェア74.9%を占めると予想されています。これは主に、神経疾患、神経変性疾患、精神疾患、睡眠障害の発生率の上昇、早期診断の必要性、革新的なポータブルおよびウェアラブルの家庭用モニタリングデバイスの利用可能性、および患者の意識の高まりによるものです。

"下肢用セグメントが予測期間中に最も高い成長率を記録"
2020年には、下肢用医療用外骨格セグメントが63.0%と大きなシェアを占めると予想されています。下肢用外骨格は、麻痺した患者や高齢者に安定性を提供し、体重負荷や移動機能を提供します。その結果、患者のリハビリテーションにおいて、その採用率が高くなっています。

"医療用外骨格市場では、予測期間中、北米が最大の地域セグメントとなる"

地域に基づいて、世界の医療用外骨格市場は、北米、欧州、アジア、およびRoWに分けられます。2020年には、北米が44.42%のシェアで市場を支配すると予想されています。高齢者人口の増加、自己支援型外骨格の需要増加、脳卒中の高い有病率、脊髄損傷（SCI）の増加などが、この地域の医療用外骨格市場の成長を促進する主な要因です。
プライマリの内訳

本レポートのために実施したプライマリーインタビューは、以下のように分類されます。

- 企業タイプ別。ティア1（40％）、ティア2（25％）、ティア3（35％）。
- 呼称別Cレベルエグゼクティブ（35％）、ディレクター（28％）、その他（37％）。
- 地域別地域別：北米（28％）、欧州（22％）、アジア（40％）、RoW（10％）。

医療用外骨格市場は、Ekso Bionics Holdings社（米国）、ReWalk Robotics社（米国）、Motorola社（米国）など、世界的に有名な数社が独占しています。(米国)、ReWalk Robotics Ltd.(イスラエル)、Parker Hannifin, Inc.(イスラエル)、Parker Hannifin Corp (米国)、CYBERDYNE Inc.(日本)、Bionik Laboratories Corp(カナダ)、Rex Bionics Ltd.(英国)、B-TEMIA (日本)などの選手がいます。(イギリス)、B-TEMIA Inc.(カナダ）、Hocoma AG（DIH Technologiesの子会社）（スイス）、Wearable Robotics SRL（イタリア）、Gogoa Mobility Robots SL（スペイン）、ExoAtlet（ルクセンブルグ）などがあります。

リサーチカバレッジ

本レポートは、世界の医療用外骨格市場の全体像を明らかにします。コンポーネント、タイプ、四肢、モビリティ、構造などの異なるセグメントにおける市場規模と今後の成長性を推定することを目的としています。また、主要な市場参加者の会社概要、最近の開発状況、主要な市場戦略とともに、詳細な競合分析を行っています。

このレポートを購入する主なメリット
本レポートは、この市場のリーダー/新規参入者が、市場全体およびサブセグメントの収益数値の最も近い近似値に関する情報を得るのに役立ちます。このレポートは、ステークホルダーが競争状況を理解し、ビジネスをより良く位置づけ、適切な市場参入戦略を計画するためのより多くの洞察を得るのに役立ちます。また、本レポートは、ステークホルダーが医療用外骨格市場の脈動を理解するのに役立ち、主要な市場のドライバー、拘束力、課題、機会に関する情報を提供します。

ページTOPに戻る

目次

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.3 MARKET SCOPE 23
1.3.1 MARKETS COVERED 23
FIGURE 1 MEDICAL EXOSKELETON MARKET SEGMENTATION 23
1.3.2 YEARS CONSIDERED 23
1.4 CURRENCY 24
1.5 LIMITATIONS 24
1.6 STAKEHOLDERS 24
1.7 SUMMARY OF CHANGES 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
FIGURE 2 RESEARCH DESIGN 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 27
2.1.2 PRIMARY DATA 28
FIGURE 3 PRIMARY SOURCES 28
2.1.2.1 Key industry insights 29
2.1.2.2 Breakdown of primaries 29
2.2 MARKET SIZE ESTIMATION 30
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 31
FIGURE 5 COMPANY REVENUE SHARE ANALYSIS ILLUSTRATION: MEDICAL EXOSKELETON MARKET 31
2.2.1 BOTTOM-UP APPROACH 32
2.2.1.1 Approach for arriving at market size using
bottom-up analysis (demand side) 32
FIGURE 6 MEDICAL EXOSKELETON MARKET: BOTTOM-UP APPROACH 33
2.2.2 TOP-DOWN APPROACH 33
2.2.2.1 Approach for arriving at market size using top-down analysis
(supply side) 34
FIGURE 7 MEDICAL EXOSKELETON MARKET: TOP-DOWN APPROACH 34
2.2.3 GROWTH FORECAST 34
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL EXOSKELETON MARKET (2021–2026) 35
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 35
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 37
FIGURE 10 DATA TRIANGULATION METHODOLOGY 37
2.4 MARKET SHARE ESTIMATION 38
2.5 RESEARCH ASSUMPTIONS 38
FIGURE 11 STUDY ASSUMPTIONS 38
2.6 RISK ASSESSMENT 39
TABLE 1 LIMITATIONS & ASSOCIATED RISKS 39
3 EXECUTIVE SUMMARY 40
FIGURE 12 MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2021–2026 (USD MILLION) 40
FIGURE 13 MEDICAL EXOSKELETON MARKET, BY TYPE, 2021–2026 (USD MILLION) 41
FIGURE 14 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2021–2026 (USD MILLION) 41
FIGURE 15 MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2021–2026 (USD MILLION) 42
FIGURE 16 GEOGRAPHIC SNAPSHOT: MEDICAL EXOSKELETON MARKET 43
4 PREMIUM INSIGHTS 44
4.1 MEDICAL EXOSKELETON MARKET: OVERVIEW 44
FIGURE 17 INCREASING DEMAND FOR EFFECTIVE REHABILITATION APPROACHES IS DRIVING MARKET GROWTH 44
4.2 MEDICAL EXOSKELETON MARKET, BY HARDWARE TYPE & REGION 45
FIGURE 18 ACTUATORS TO HOLD LARGEST SHARE OF MEDICAL EXOSKELETON HARDWARE MARKET IN 2021 45
4.3 MEDICAL EXOSKELETON MARKET, BY EXTREMITY 46
FIGURE 19 UPPER EXTREMITY SEGMENT TO GROW AT HIGHEST CAGR FROM 2021 TO 2026 46
4.4 GEOGRAPHIC SNAPSHOT: MEDICAL EXOSKELETON MARKET 46
FIGURE 20 ASIA TO BE FASTEST-GROWING REGIONAL SEGMENT DURING FORECAST PERIOD 46
5 MARKET OVERVIEW 47
5.1 INTRODUCTION 47
5.2 MARKET DYNAMICS 47
FIGURE 21 MEDICAL EXOSKELETON MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47
5.2.1 DRIVERS 48
5.2.1.1 Increasing number of people with physical disabilities and subsequent growth in demand for effective rehabilitation approaches 48
FIGURE 22 AGING POPULATION, BY REGION, 2019 VS. 2050 48
FIGURE 23 PERCENTAGE OF DISABLED PEOPLE IN US, 2015–2020 49
FIGURE 24 PERCENTAGE OF DISABLED PEOPLE IN US, BY AGE GROUP, 2018 50
FIGURE 25 PERCENTAGE OF DISABLED PEOPLE IN US, BY TYPE OF DISABILITY, 2018 50
5.2.1.2 Agreements and collaborations among companies and research organizations for development of exoskeleton technology 51
5.2.1.3 Huge investments for development of exoskeleton technology 51
5.2.2 RESTRAINTS 52
5.2.2.1 Regulatory challenges for securing approvals for medical exoskeletons 52
 
5.2.3 OPPORTUNITIES 52
5.2.3.1 Introduction of soft actuators 52
5.2.3.2 Increasing insurance coverage for medical exoskeletons in several countries 53
5.2.4 CHALLENGES 53
5.2.4.1 High equipment cost 53
TABLE 2 COST OF MEDICAL EXOSKELETONS 54
5.2.4.2 Safety concerns associated with medical exoskeletons 54
5.2.4.3 Long-term power supply requirements 54
5.3 IMPACT OF COVID-19 ON MEDICAL EXOSKELETON MARKET 55
5.3.1 VALUE CHAIN ANALYSIS 55
FIGURE 26 VALUE CHAIN ANALYSIS OF MEDICAL EXOSKELETON MARKET 55
5.3.2 ECOSYSTEM 56
FIGURE 27 MEDICAL EXOSKELETON ECOSYSTEM 56
TABLE 3 MEDICAL EXOSKELETON MARKET SUPPLY CHAIN 57
5.4 PORTER’S FIVE FORCES ANALYSIS 58
TABLE 4 MEDICAL EXOSKELETON MARKET: PORTER’S FIVE FORCES ANALYSIS 58
5.4.1 DEGREE OF COMPETITION 58
5.4.2 BARGAINING POWER OF SUPPLIERS 58
5.4.3 BARGAINING POWER OF BUYERS 59
5.4.4 THREAT OF SUBSTITUTES 59
5.4.5 THREAT OF NEW ENTRANTS 59
5.5 CASE STUDIES FOR MEDICAL EXOSKELETON MARKET 59
5.5.1 PEER-REVIEWED CASE STUDY DEMONSTRATES VARIOUS HEALTH IMPROVEMENTS FOLLOWING REWALK EXOSKELETON USE 59
5.5.2 EKSO BIONICS IMPROVES PATIENT MOBILITY WITH HELP OF VODAFONE-MANAGED IOT CONNECTIVITY PLATFORM 59
5.5.3 RLS MAGNETIC ENCODERS ENABLED MARSI BIONICS TO DESIGN AND BUILD EXOSKELETON ORTHOPAEDIC DEVICES 60
5.6 TECHNOLOGY ANALYSIS 60
5.7 FUTURE TRENDS OF MEDICAL EXOSKELETON MARKET 61
5.8 PATENT ANALYSIS 62
5.9 STANDARDS AND REGULATIONS RELATED TO MEDICAL EXOSKELETON MARKET 64
6 MEDICAL EXOSKELETON MARKET, BY COMPONENT 66
6.1 INTRODUCTION 67
TABLE 5 MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 67
6.2 HARDWARE 67
TABLE 6 MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 68
TABLE 7 EXOSKELETON MARKET FOR HARDWARE, BY REGION,
2019–2026 (USD MILLION) 68
6.2.1 SENSORS 68
6.2.1.1 Sensors help exoskeletons to acquire knowledge about surrounding environment 68
TABLE 8 MEDICAL EXOSKELETON HARDWARE MARKET FOR SENSORS , BY REGION, 2019–2026 (USD MILLION) 69
6.2.1.2 Gyroscopes 69
6.2.1.2.1 Gyroscopes are used in exoskeletons for orientation and rotation measurements 69
6.2.1.3 Microphones 69
6.2.1.3.1 Microphones assist medical exoskeletons in sound source localization by separating unwanted sound signals from other positions 69
6.2.1.4 Accelerometers 70
6.2.1.4.1 Accelerometers are integrated into medical exoskeletons for measurement of non-gravitational acceleration forces 70
6.2.1.5 Tilt sensors 70
6.2.1.5.1 Tilt sensors are used in medical exoskeletons to measure tilt angle with respect to Earth’s ground plane 70
6.2.1.6 Force/torque sensors 70
6.2.1.6.1 Force/torque sensors help medical exoskeletons control interaction with objects in manipulation tasks 70
6.2.1.7 Position sensors 70
6.2.1.7.1 Position sensors are used to measure distance traveled by medical exoskeletons from their origin 70
6.2.1.8 Others 71
6.2.2 ACTUATORS 71
6.2.2.1 Actuators are used to set systems in motion and control their mechanism 71
TABLE 9 MEDICAL EXOSKELETON HARDWARE MARKET FOR ACTUATORS, BY REGION, 2019–2026 (USD MILLION) 71
6.2.2.2 Electrical 71
6.2.2.2.1 Electrical actuators use motors to convert electrical energy into mechanical energy 71
6.2.2.3 Pneumatic 72
6.2.2.3.1 Pneumatic actuators convert electric energy into mechanical motion and are similar to capacitors in operation 72
6.2.2.4 Hydraulic 72
6.2.2.4.1 Hydraulic actuators are used in medical exoskeleton applications where heavy force and speed are required 72
6.2.2.5 Piezoelectric 72
6.2.2.5.1 Piezoelectric actuators use converse piezoelectric effect for precise positioning of systems, ultrasonic actuators, and microactuators in exoskeletons 72
6.2.3 POWER SOURCES 72
6.2.3.1 Exoskeletons mainly use lead-acid batteries, fuel cells, and lithium-ion batteries for electrical connectivity 72
 
TABLE 10 MEDICAL EXOSKELETON HARDWARE MARKET FOR POWER SOURCES ,
BY REGION, 2019–2026 (USD MILLION) 73
6.2.4 CONTROL SYSTEMS/CONTROLLERS 73
6.2.4.1 Controllers allow all parts of exoskeletons to operate together 73
TABLE 11 MEDICAL EXOSKELETON HARDWARE MARKET FOR CONTROL SYSTEMS,
BY REGION, 2019–2026 (USD MILLION) 73
6.2.5 OTHERS 74
TABLE 12 MEDICAL EXOSKELETON HARDWARE MARKET FOR OTHER HARDWARE COMPONENTS, BY REGION, 2019–2026 (USD MILLION) 74
6.3 SOFTWARE 74
6.3.1 SOFTWARE HELP TO PROGRAM EXOSKELETONS ACCORDING TO TASKS REQUIRED TO BE PERFORMED BY THEM 74
TABLE 13 MEDICAL EXOSKELETON MARKET FOR SOFTWARE , BY REGION,
2019–2026 (USD MILLION) 75
7 MEDICAL EXOSKELETON MARKET, BY TYPE 76
7.1 INTRODUCTION 77
TABLE 14 MEDICAL EXOSKELETON MARKET, BY TYPE, 2019–2026 (USD MILLION) 77
7.2 POWERED 77
7.2.1 POWERED EXOSKELETONS ARE USUALLY POWERED BY ELECTRIC MOTORS, ACTUATORS, SENSORS, AND BATTERIES 77
TABLE 15 POWERED EXOSKELETON MARKET, BY REGION, 2019–2026 (USD MILLION) 78
7.3 PASSIVE 78
7.3.1 PASSIVE EXOSKELETONS REQUIRE NO ELECTRIC POWER AND ARE SIMPLER IN COMPARISON TO POWERED EXOSKELETONS 78
TABLE 16 PASSIVE EXOSKELETON MARKET, BY REGION, 2019–2026 (USD MILLION) 78
8 MEDICAL EXOSKELETON MARKET, BY EXTREMITY 79
8.1 INTRODUCTION 80
TABLE 17 MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2019–2026 (USD MILLION) 80
TABLE 18 MEDICAL EXOSKELETON MARKET, BY EXTREMITY, 2019–2026 (UNITS) 80
8.2 LOWER EXTREMITY 80
8.2.1 LOWER EXTREMITY EXOSKELETONS ARE DESIGNED TO PROVIDE PROTECTION, ASSISTANCE, AND SUPPORT TO LOWER LIMBS OF HUMAN BODY 80
TABLE 19 LOWER EXTREMITY MEDICAL EXOSKELETON MARKET, BY REGION,
2019–2026 (USD MILLION) 81
8.3 UPPER EXTREMITY 81
8.3.1 UPPER EXTREMITY EXOSKELETONS PROVIDE SUPPORT TO UPPER LIMBS FOR STRENGTHENING OR AUGMENTATION 81
TABLE 20 UPPER EXTREMITY MEDICAL EXOSKELETON MARKET, BY REGION,
2019–2026 (USD MILLION) 82
 
8.4 FULL BODY 82
8.4.1 FULL-BODY EXOSKELETONS ARE DESIGNED FOR HUMAN BODY STRENGTH AUGMENTATION 82
TABLE 21 FULL BODY MEDICAL EXOSKELETON MARKET, BY REGION,
2019–2026 (USD MILLION) 82
9 MEDICAL EXOSKELETON MARKET, BY STRUCTURE 83
9.1 INTRODUCTION 83
9.2 RIGID EXOSKELETONS 83
9.2.1 RIGID EXOSKELETONS CAN DELIVER HIGHER FORCES QUICKLY AND ACCURATELY, EVEN IN EXTREME CASES OF PARALYSIS 83
9.3 SOFT EXOSKELETONS 83
9.3.1 SOFT EXOSKELETONS REDUCE RISKS OF INJURY, ARE EASIER TO FIT,
AND IMPROVE MANEUVERABILITY 83
10 MEDICAL EXOSKELETON MARKET, BY MOBILITY 84
10.1 INTRODUCTION 85
TABLE 22 MEDICAL EXOSKELETON MARKET, BY MOBILITY, 2019–2026 (USD MILLION) 85
10.2 STATIONARY 85
10.2.1 STATIONARY EXOSKELETONS ARE MOSTLY USED IN MEDICAL APPLICATIONS 85
TABLE 23 STATIONARY MEDICAL EXOSKELETONS MARKET, BY REGION,
2019–2026 (USD MILLION) 86
10.3 MOBILE 86
10.3.1 MOBILE EXOSKELETONS PROVIDE EFFECTIVE AND REPETITIVE GAIT TRAINING FOR DISABLED PATIENTS 86
TABLE 24 MOBILE MEDICAL EXOSKELETONS MARKET, BY REGION,
2019–2026 (USD MILLION) 87
11 GEOGRAPHIC ANALYSIS 88
11.1 INTRODUCTION 89
TABLE 25 MEDICAL EXOSKELETON MARKET, BY REGION, 2019–2026 (USD MILLION) 89
TABLE 26 MEDICAL EXOSKELETON MARKET, BY REGION, 2019–2026 (UNITS) 89
11.2 NORTH AMERICA 89
FIGURE 28 SNAPSHOT: EXOSKELETON MARKET IN NORTH AMERICA 90
TABLE 27 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 90
TABLE 28 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 91
TABLE 29 NORTH AMERICA: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE, 2019–2026 (USD MILLION) 91
TABLE 30 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 91
TABLE 31 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 92
TABLE 32 NORTH AMERICA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2019–2026 (USD MILLION) 92
11.2.1 US 92
11.2.1.1 Increasing use of exoskeletons in healthcare to fuel market
growth in US 92
TABLE 33 US: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 93
TABLE 34 US: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019–2026 (USD MILLION) 93
TABLE 35 US: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 93
11.2.2 CANADA 93
11.2.2.1 Growing geriatric population and surging demand for personal assistance exoskeletons to drive market growth in Canada 93
TABLE 36 CANADA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 94
TABLE 37 CANADA: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 94
TABLE 38 CANADA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 94
11.3 EUROPE 94
FIGURE 29 SNAPSHOT: MEDICAL EXOSKELETON MARKET IN EUROPE 95
TABLE 39 EUROPE: MEDICAL EXOSKELETON MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 95
TABLE 40 EUROPE: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 96
TABLE 41 EUROPE: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 96
TABLE 42 EUROPE: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 96
TABLE 43 EUROPE: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 96
TABLE 44 EUROPE: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2019–2026 (USD MILLION) 97
11.3.1 UK 97
11.3.1.1 Demand for exoskeletons in healthcare and personal assistance applications to support market growth 97
TABLE 45 UK: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 97
TABLE 46 UK: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019–2026 (USD MILLION) 98
TABLE 47 UK: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 98
11.3.2 GERMANY 98
11.3.2.1 Growing elderly population and increasing prevalence of diseases such as stroke are expected to drive market growth in Germany 98
TABLE 48 GERMANY: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 99
TABLE 49 GERMANY: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 99
TABLE 50 GERMANY: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 99
11.3.3 FRANCE 100
11.3.3.1 Rising geriatric population and growing incidences of chronic diseases are expected to propel demand for medical exoskeletons in France 100
TABLE 51 FRANCE: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 100
TABLE 52 FRANCE: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 100
TABLE 53 FRANCE: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 101
11.3.4 REST OF EUROPE (ROE) 101
TABLE 54 ROE: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 101
TABLE 55 ROE: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019–2026 (USD MILLION) 102
11.4 ASIA 102
TABLE 56 ASIA: MEDICAL EXOSKELETON MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 102
TABLE 57 ASIA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 103
TABLE 58 ASIA: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 59 ASIA: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 103
TABLE 60 ASIA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 103
TABLE 61 ASIA: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2019–2026 (USD MILLION) 104
11.4.1 JAPAN 104
11.4.1.1 Aging population and reduced workforce would fuel demand for exoskeletons in Japan in near future 104
TABLE 62 JAPAN: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 104
TABLE 63 JAPAN: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 105
TABLE 64 JAPAN: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 105
11.4.2 CHINA 105
11.4.2.1 Emergence of new exoskeleton companies in China to augment market growth during forecast period 105
TABLE 65 CHINA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 106
TABLE 66 CHINA: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 106
TABLE 67 CHINA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 106
11.4.3 INDIA 106
11.4.3.1 Initiation of various automotive manufacturing projects in India would fuel exoskeleton market growth in coming years 106
TABLE 68 INDIA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 107
TABLE 69 INDIA: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 107
TABLE 70 INDIA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 107
11.4.4 REST OF ASIA 107
TABLE 71 ROA: MEDICAL EXOSKELETON MARKET, BY COMPONENT,
2019–2026 (USD MILLION) 107
TABLE 72 ROA: MEDICAL EXOSKELETON MARKET, BY TYPE, 2019–2026 (USD MILLION) 108
TABLE 73 ROA: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 108
11.5 REST OF THE WORLD 108
TABLE 74 ROW: MEDICAL EXOSKELETON MARKET, BY COMPONENT, 2019–2026 (USD MILLION) 109
TABLE 75 ROW: MEDICAL EXOSKELETON HARDWARE MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 76 ROW: MEDICAL EXOSKELETON MARKET, BY TYPE,
2019–2026 (USD MILLION) 109
TABLE 77 ROW: MEDICAL EXOSKELETON MARKET, BY MOBILITY,
2019–2026 (USD MILLION) 109
TABLE 78 ROW: MEDICAL EXOSKELETON MARKET, BY EXTREMITY,
2019–2026 (USD MILLION) 110
12 COMPETITIVE LANDSCAPE 111
12.1 OVERVIEW 111
FIGURE 30 KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN MEDICAL EXOSKELETON MARKET (2020–2021) 112
12.2 MARKET SHARE ANALYSIS: MEDICAL EXOSKELETON MARKET, 2020 113
TABLE 79 DEGREE OF COMPETITION 113
12.3 COMPANY EVALUATION QUADRANT 114
12.3.1 STAR 115
12.3.2 EMERGING LEADER 115
12.3.3 PERVASIVE 115
12.3.4 PARTICIPANT 115
FIGURE 31 MEDICAL EXOSKELETON MARKET: COMPANY EVALUATION QUADRANT,
2020 (OVERALL MARKET) 116
12.4 COMPANY EVALUATION QUADRANT FOR EMERGING PLAYERS 117
12.4.1 PROGRESSIVE COMPANY 117
12.4.2 RESPONSIVE COMPANY 117
12.4.3 DYNAMIC COMPANY 117
12.4.4 STARTING BLOCK 117
FIGURE 32 MEDICAL EXOSKELETON MARKET: COMPANY EVALUATION QUADRANT,
2020 (EMERGING PLAYERS) 118
 
12.5 COMPETITIVE BENCHMARKING 119
12.5.1 OVERALL COMPANY FOOTPRINT 119
TABLE 80 OVERALL COMPANY FOOTPRINT 119
12.5.2 COMPANY PRODUCT TYPE FOOTPRINT 119
TABLE 81 COMPANY PRODUCT TYPE FOOTPRINT 119
12.5.3 COMPANY PRODUCT MOBILITY FOOTPRINT 120
TABLE 82 COMPANY PRODUCT MOBILITY FOOTPRINT 120
12.5.4 COMPANY REGION FOOTPRINT 120
TABLE 83 COMPANY REGION FOOTPRINT 120
12.6 COMPETITIVE SCENARIO 121
12.6.1 PRODUCT OR SERVICE LAUNCHES 121
TABLE 84 PRODUCT LAUNCHES & DEVELOPMENTS, 2020–2021 121
12.6.2 DEALS 123
TABLE 85 DEALS 123
12.6.3 OTHERS 127
TABLE 86 OTHERS 127
13 COMPANY PROFILES 128
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
13.1 CYBERDYNE INC. 128
TABLE 87 CYBERDYNE INC.: BUSINESS OVERVIEW 128
FIGURE 33 CYBERDYNE INC.: COMPANY SNAPSHOT (2020) 128
13.2 EKSO BIONICS 132
TABLE 88 EKSO BIONICS: BUSINESS OVERVIEW 132
FIGURE 34 COMPANY SNAPSHOT: EKSO BIONICS (2020) 133
13.3 REWALK ROBOTICS 136
TABLE 89 REWALK ROBOTICS: BUSINESS OVERVIEW 136
FIGURE 35 COMPANY SNAPSHOT: REWALK ROBOTICS (2020) 137
13.4 BIONIK LABORATORIES 140
TABLE 90 BIONIK LABORATORIES: BUSINESS OVERVIEW 140
FIGURE 36 BIONIK LABORATORIES: COMPANY SNAPSHOT 140
13.5 REX BIONICS 143
TABLE 91 REX BIONICS: BUSINESS OVERVIEW 143
13.6 PARKER HANNIFIN CORP 145
TABLE 92 PARKER HANNIFIN CORP: BUSINESS OVERVIEW 145
FIGURE 37 COMPANY SNAPSHOT: PARKER HANNIFIN CORP (2020) 146
13.7 B-TEMIA INC. 148
TABLE 93 B-TEMIA INC: BUSINESS OVERVIEW 148
13.8 BIOVENTUS 150
TABLE 94 BIOVENTUS BUSINESS OVERVIEW 150
FIGURE 38 COMPANY SNAPSHOT: BIOVENTUS (2020) 151
13.9 HOCOMA AG (A SUBSIDIARY OF DIH TECHNOLOGIES) 153
TABLE 95 HOCOMA AG: BUSINESS OVERVIEW 153
13.10 WEARABLE ROBOTICS 155
TABLE 96 WEARABLE ROBOTICS: BUSINESS OVERVIEW 155
13.11 OTHER KEY PLAYERS 156
13.11.1 GOGOA MOBILITY ROBOTS 156
13.11.2 EXOATLET 157
13.11.3 MEDITOUCH 158
13.11.4 SUITX 159
13.11.5 MEDEXO ROBOTICS 160
13.11.6 P & S MECHANICS 161
13.11.7 MARSI BIONICS S.L. 162
13.11.8 REHAB ROBOTICS 163
13.11.9 FOURIER INTELLIGENCE 164
13.11.10 MYOMO INC 165
13.11.11 FOCAL MEDITECH 166
13.11.12 HONDA MOTORS 167
13.11.13 WANDERCRAFT 168
13.11.14 BAMA TEKNOLOJI 169
13.11.15 TWIICE 170
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
14 APPENDIX 171
14.1 INSIGHTS FROM INDUSTRY EXPERTS 171
14.2 DISCUSSION GUIDE 172
14.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 175
14.4 AVAILABLE CUSTOMIZATIONS 177
14.5 RELATED REPORTS 177
14.6 AUTHOR DETAILS 178